A Prospective Randomized Comparative Dosing Trial of Ranibizumab In Bevacizumab-Resistant Diabetic Macular Edema: The REACT Study

PURPOSE: To assess the efficacy of ranibizumab for persistent diabetic macular edema (DME) previously treated with bevacizumab and compare monthly vs treat-and-extend (TAE) dosing. DESIGN: 12-month, open-label, prospective randomized comparative dosing study. PARTICIPANTS: 27 participants with persi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ophthalmol Retina
Main Authors: Ehlers, Justis P., Wang, Kevin, Singh, Rishi P., Babiuch, Amy S., Schachat, Andrew P., Yuan, Alex, Reese, Jamie L., Stiegel, Laura, Srivastava, Sunil K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5839652/
https://ncbi.nlm.nih.gov/pubmed/29527585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.oret.2017.07.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados